Amyris (AMRS) Misses Q3 EPS by 37c

Amyris (NASDAQ: AMRS) reported Q3 EPS of ($1.14), $0.37 worse than the analyst estimate of ($0.77). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $30.64 million.

For earnings history and earnings-related data on Amyris (AMRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M